FDA Clearance Tracker · K090626
ENDOSERTER
Last checked: Nov 20, 2026Latest source record: Jan 21, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Jan 21, 2011
Substantially Equivalent
Time to decision
683 days
Received Mar 9, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K090626
- Device name
- ENDOSERTER
- Applicant
- Ocular Systems, Inc.
- Applicant location
- Winston-Salem, NC
- Received
- Mar 9, 2009
- Decided
- Jan 21, 2011
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class I
- Regulation
- 21 CFR 886.4300
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code OTZ (Graft Insertion Instrument For Endothelial Keratoplasty).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K090626
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Ocular Systems, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.